Product Code: PHA1256
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
"The Cell and Gene Therapy Cold Chain Logistics Market Report 2023-2033:" This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Favourable Initiatives and Programs for Easier Access to Cell and Gene Therapy Driving Market Growth
Patient access programs are initiatives designed to facilitate the access of patients with rare or serious diseases to cell and gene therapies. These programs offer various types of support to ensure that patients receive effective therapy in a timely manner. Support may include financial assistance, education and awareness, regulatory guidance, and transportation assistance. Due to the high cost of these therapies, affordability becomes a significant challenge for patients. To address this issue, governments and biopharmaceutical companies have implemented patient access programs that provide financial aid and reimbursement schemes, aiming to extend the reach of these therapies to patients. For examples, Novartis provide Patient Assistance NOW Program, a patient access programs for cell and gene therapy. This program offers financial assistance and support services to eligible patients receiving Kymriah and other medications from Novartis.
However, the cost associated with the storage and temperature-controlled transport of biologics is essential to maintain the integrity and effectiveness of these specialized medicines. Specifically, biologics that necessitate ultra-low temperature storage and transportation, like gene therapies and cell-based therapies, can incur significant expenses. This high cost is expected to act as a limiting factor for the growth of the cell and gene therapy cold chain logistics market.
Stringent Government Regulations to Hamper Industry Growth
Various governments have implemented stringent regulations regarding the importation of cell and gene therapeutics. Regulatory bodies require manufacturers to meet specific safety standards before granting market approval and allowing distribution. Similar rules apply to the importation of biologics, including vaccines and cell and gene therapies. Certain countries have additional regulations such as import permits, labeling requirements, storage information, and customs clearance documents for imported biologics. Logistic companies, along with their regulatory teams, must provide all necessary documentation to ensure a safe and legal process through the regulatory authorities. Moreover, such regulations can present obstacles to importing biotherapeutics into developing countries with less established regulatory frameworks, thus limiting patient access to these treatments in those regions.
What Questions Should You Ask before Buying a Market Research Report?
- How is the vaccine contract manufacturing market evolving?
- What is driving and restraining the vaccine contract manufacturing market?
- How will each vaccine contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each vaccine contract manufacturing submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the vaccine contract manufacturing projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of vaccine contract manufacturing projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the vaccine contract manufacturing market?
- Where is the vaccine contract manufacturing market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the vaccine contract manufacturing market today, and over the next 10 years:
- Our 322-page report provides 119 tables and 187 charts/graphs exclusively to you
- The report highlights key lucrative areas in the industry so you can target them - NOW
- It contains in-depth analysis of global, regional and national sales and growth
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the vaccine contract manufacturing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
- You will find original analyses, with business outlooks and developments
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising vaccine contract manufacturing prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.
Segments Covered in the Report:
Component
- Cryogenic Shippers
- Cryogenic Storage Freezers
- Ultra-Low Freezers
- Cold Chain Management Systems
- Shipment and Storage Medium
- Cryogenic Packout Kits
- Others
Services
- Transportation
- Storage
- Packaging
Mode of Transport
- Air Transport
- Ground Transport
- Water Transports
Holding Temperature Range
- Cryogenic
- Refrigerated
- Ambient
- Others
End-users
- Biopharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and xx leading national markets:
North America
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
The report also includes profiles and for some of the leading companies in the Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth:
- AmerisourceBergen Corporation
- Arvato Supply Chain Solutions SE
- Be The Match BioTherapies
- BioLife Solutions, Inc
- BioStor Sytems, Inc
- Cardinal Health, Inc
|
- Catalent Inc
- Cryoport, Inc
- Marken (a UPS Company)
- Polar Express Transportation
- Thermo Fisher Scientific Inc
- Yourway Biopharma Services Company
|
Overall world revenue for Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033 in terms of value the market will surpass US$1,655 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033 report help you?
In summary, our 320+ page report provides you with the following knowledge:
- Revenue forecasts to 2033 for Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033 Market, with forecasts for component, services, mode of transport, holding temperature range, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 12 of the major companies involved in the Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Cell and Gene Therapy Cold Chain Logistics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
Table of Contents
1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Cell and Gene Therapy Cold Chain Logistics Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report
- 1.6 Who is This Report for?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Reports
- 1.10 About
2 Executive Summary
3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 High Prevalence of Cancer and Genetic Disorders
- 3.2.1.2 Increasing Adoption of Gene and Cell Therapies
- 3.2.1.3 Advancements in Storage and Transportation of Biologics
- 3.2.1.4 Increasing Strategic Initiatives Among Market Players
- 3.2.2 Market Restraining Factors
- 3.2.2.1 High Cost of Storage
- 3.2.2.2 Stringent Government Regulations
- 3.2.3 Market Opportunities
- 3.2.3.1 Strong Clinical Pipeline and Increasing Approval for Cell and Gene Therapy Products
- 3.2.3.2 Favourable Initiatives and Programs for Easier Access to Cell and Gene Therapy
- 3.3 COVID-19 Impact Analysis
- 3.4 Porter's Five Forces Analysis
- 3.4.1 Bargaining Power of Suppliers
- 3.4.2 Bargaining Power of Buyers
- 3.4.3 Competitive Rivalry
- 3.4.4 Threat from Substitutes
- 3.4.5 Threat of New Entrants
- 3.5 PEST Analysis
4 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Components
- 4.1 Key Findings
- 4.2 Components Segment: Market Attractiveness Index
- 4.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
- 4.4 Cryogenic Shippers
- 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.4.2 Market Share by Region, 2023 & 2033 (%)
- 4.5 Cryogenic Storage Freezers
- 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.5.2 Market Share by Region, 2023 & 2033 (%)
- 4.6 Ultra-Low Freezers
- 4.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.6.2 Market Share by Region, 2023 & 2033 (%)
- 4.7 Cold Chain Management Systems
- 4.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.7.2 Market Share by Region, 2023 & 2033 (%)
- 4.8 Shipment and Storage Medium
- 4.8.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.8.2 Market Share by Region, 2023 & 2033 (%)
- 4.9 Cryogenic Packout Kits
- 4.9.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.9.2 Market Share by Region, 2023 & 2033 (%)
- 4.10 Others
- 4.10.1 Market Size by Region, 2023-2033 (US$ Million)
- 4.10.2 Market Share by Region, 2023 & 2033 (%)
5 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Services
- 5.1 Key Findings
- 5.2 Services Segment: Market Attractiveness Index
- 5.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
- 5.4 Transportation
- 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.4.2 Market Share by Region, 2023 & 2033 (%)
- 5.5 Storage
- 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.5.2 Market Share by Region, 2023 & 2033 (%)
- 5.6 Packaging
- 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 5.6.2 Market Share by Region, 2023 & 2033 (%)
6 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Mode of Transport
- 6.1 Key Findings
- 6.2 Mode of Transport Segment: Market Attractiveness Index
- 6.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
- 6.4 Air
- 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.4.2 Market Share by Region, 2023 & 2033 (%)
- 6.5 Ground
- 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.5.2 Market Share by Region, 2023 & 2033 (%)
- 6.6 Water
- 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Holding Temperature
- 7.1 Key Findings
- 7.2 Holding Temperature Segment: Market Attractiveness Index
- 7.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
- 7.4 Cryogenic
- 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.4.2 Market Share by Region, 2023 & 2033 (%)
- 7.5 Refrigerated
- 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.5.2 Market Share by Region, 2023 & 2033 (%)
- 7.6 Ambient
- 7.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.6.2 Market Share by Region, 2023 & 2033 (%)
- 7.7 Others
- 7.7.1 Market Size by Region, 2023-2033 (US$ Million)
- 7.7.2 Market Share by Region, 2023 & 2033 (%)
8 Cell and Gene Therapy Cold Chain Logistics Market Analysis by End-users
- 8.1 Key Findings
- 8.2 End-users Segment: Market Attractiveness Index
- 8.3 Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-users
- 8.4 Biopharmaceutical & Biotechnology Companies
- 8.4.1 Market Size by Region, 2023-2033 (US$ Million)
- 8.4.2 Market Share by Region, 2023 & 2033 (%)
- 8.5 Academic & Research Institutes
- 8.5.1 Market Size by Region, 2023-2033 (US$ Million)
- 8.5.2 Market Share by Region, 2023 & 2033 (%)
- 8.6 Others
- 8.6.1 Market Size by Region, 2023-2033 (US$ Million)
- 8.6.2 Market Share by Region, 2023 & 2033 (%)
9 Cell and Gene Therapy Cold Chain Logistics Market Analysis by Region
- 9.1 Key Findings
- 9.2 Regional Market Size Estimation and Forecast
10 North America Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 10.1 Key Findings
- 10.2 North America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
- 10.3 North America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
- 10.4 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
- 10.5 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
- 10.6 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
- 10.7 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
- 10.8 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
- 10.9 North America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-users
- 10.10 U.S. Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 10.11 Canada Cell and Gene Therapy Cold Chain Logistics Market Analysis
11 Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.1 Key Findings
- 11.2 Europe Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
- 11.3 Europe Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
- 11.4 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
- 11.5 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
- 11.6 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
- 11.7 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
- 11.8 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
- 11.9 Europe Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-users
- 11.10 Germany Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.11 UK Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.12 France Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.13 Italy Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.14 Spain Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.15 Russia Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 11.16 Rest of Europe Cell and Gene Therapy Cold Chain Logistics Market Analysis
12 Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 12.1 Key Findings
- 12.2 Asia Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
- 12.3 Asia Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
- 12.4 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
- 12.5 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
- 12.6 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
- 12.7 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
- 12.8 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
- 12.9 Asia Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-users
- 12.10 Japan Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 12.11 China Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 12.12 India Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 12.13 Australia Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 12.14 South Korea Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 12.15 Rest of Asia Cell and Gene Therapy Cold Chain Logistics Market Analysis
13 Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 13.1 Key Findings
- 13.2 Latin America Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
- 13.3 Latin America Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
- 13.4 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
- 13.5 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
- 13.6 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
- 13.7 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
- 13.8 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
- 13.9 Latin America Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-users
- 13.10 Brazil Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 13.11 Mexico Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 13.12 Argentina Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 13.13 Rest of Latin America Cell and Gene Therapy Cold Chain Logistics Market Analysis
14 MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 14.1 Key Findings
- 14.2 MEA Cell and Gene Therapy Cold Chain Logistics Market Attractiveness Index
- 14.3 MEA Cell and Gene Therapy Cold Chain Logistics Market by Country, 2023, 2028 & 2033 (US$ Million)
- 14.4 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Country
- 14.5 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Components
- 14.6 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Services
- 14.7 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Mode of Transport
- 14.8 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by Holding Temperature
- 14.9 MEA Cell and Gene Therapy Cold Chain Logistics Market Size Estimation and Forecast by End-users
- 14.10 GCC Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 14.11 South Africa Cell and Gene Therapy Cold Chain Logistics Market Analysis
- 14.12 Rest of MEA Cell and Gene Therapy Cold Chain Logistics Market Analysis
15 Company Profiles
- 15.1 Company Share Analysis, 2022
- 15.2 Strategic Outlook
- 15.3 AmerisourceBergen Corporation
- 15.3.1 Company Snapshot
- 15.3.2 Company Overview
- 15.3.3 Financial Analysis
- 15.3.3.1 Net Revenue, 2017-2022
- 15.3.3.2 Regional Market Shares, 2022
- 15.3.3.3 Segment Market Shares, 2022
- 15.3.4 Product Benchmarking
- 15.3.5 Strategic Outlook
- 15.4 Arvato Supply Chain Solutions SE
- 15.4.1 Company Snapshot
- 15.4.2 Company Overview
- 15.4.3 Product Benchmarking
- 15.4.4 Strategic Outlook
- 15.5 Be The Match BioTherapies
- 15.5.1 Company Snapshot
- 15.5.2 Company Overview
- 15.5.3 Product Benchmarking
- 15.5.4 Strategic Outlook
- 15.6 BioLife Solutions, Inc
- 15.6.1 Company Snapshot
- 15.6.2 Company Overview
- 15.6.3 Financial Analysis
- 15.6.3.1 Net Revenue, 2017-2022
- 15.6.3.2 Segment Market Shares, 2022
- 15.6.4 Product Benchmarking
- 15.6.5 Strategic Outlook
- 15.7 Cardinal Health Inc
- 15.7.1 Company Snapshot
- 15.7.2 Company Overview
- 15.7.3 Financial Analysis
- 15.7.3.1 Net Revenue, 2017-2022
- 15.7.3.2 Regional Market Shares, 2022
- 15.7.3.3 Segment Market Shares, 2022
- 15.7.4 Product Benchmarking
- 15.7.5 Strategic Outlook
- 15.8 Catalent, Inc.
- 15.8.1 Company Snapshot
- 15.8.2 Company Overview
- 15.8.3 Financial Analysis
- 15.8.3.1 Net Revenue, 2017-2022
- 15.8.3.2 R&D, 2017-2022
- 15.8.3.3 Regional Market Shares, 2022
- 15.8.3.4 Segment Market Shares, 2022
- 15.8.4 Product Benchmarking
- 15.8.5 Strategic Outlook
- 15.9 Cryoport, Inc.
- 15.9.1 Company Snapshot
- 15.9.2 Company Overview
- 15.9.3 Financial Analysis
- 15.9.3.1 Net Revenue, 2017-2022
- 15.9.3.2 Regional Market Shares, 2022
- 15.9.3.3 Segment Market Shares, 2022
- 15.9.4 Product Benchmarking
- 15.9.5 Strategic Outlook
- 15.10 BioStor Sytems, Inc.
- 15.10.1 Company Snapshot
- 15.10.2 Company Overview
- 15.10.3 Product Benchmarking
- 15.11 Marken (a UPS Company)
- 15.11.1 Company Snapshot
- 15.11.2 Company Overview
- 15.11.3 Financial Analysis
- 15.11.3.1 Net Revenue, 2017-2022
- 15.11.3.2 Regional Market Shares, 2022
- 15.11.3.3 Segment Market Shares, 2022
- 15.11.4 Product Benchmarking
- 15.11.5 Strategic Outlook
- 15.12 Polar Express Transportation
- 15.12.1 Company Snapshot
- 15.12.2 Company Overview
- 15.12.3 Product Benchmarking
- 15.13 Thermo Fisher Scientific Inc.
- 15.13.1 Company Snapshot
- 15.13.2 Company Overview
- 15.13.3 Financial Analysis
- 15.13.3.1 Net Revenue, 2017-2022
- 15.13.3.2 R&D, 2017-2022
- 15.13.3.3 Regional Market Shares, 2022
- 15.13.3.4 Segment Market Shares, 2022
- 15.13.4 Product Benchmarking
- 15.13.5 Strategic Outlook
- 15.14 Yourway Biopharma Services Company
- 15.14.1 Company Snapshot
- 15.14.2 Company Overview
- 15.14.3 Product Benchmarking
16 Conclusion and Recommendations
- 16.1 Concluding Remarks from
- 16.2 Recommendations for Market Players